PMA device
Dexcom Seven System
Dexcom, Inc. · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Oct 22, 2007, newest Feb 13, 2009Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
9
Naming "Dexcom Seven"
MAUDE reports
9
Brand "Dexcom Seven", since 2015
PubMed studies
19
Mentioning "Dexcom Seven"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Dexcom Seven System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- DEXCOM SEVEN SYSTEMPMA supplement
P050012-S016 · Decided Feb 13, 2009 · 193 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- THE DEXCOM SEVEN CONTINUOUS GLUCOSE MONITORING SYSTEMPMA supplement
P050012-S017 · Decided Dec 3, 2008 · 71 days after receipt · Normal 180 Day Track
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
- DEXCOM SEVEN SYSTEMPMA supplement
P050012-S012 · Decided Oct 22, 2007 · 63 days after receipt · Normal 180 Day Track No User Fee
Device type: Sensor, glucose, invasive (MDS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Dexcom Seven", any status and sponsor, newest update first.
Kangbuk Samsung HospitalAcademic, hospital or other
NCT06275971 · 68 participants (planned) · Start Nov 24, 2022 · Primary completion Jun 30, 2024
Device: Dexcom G6; SMBG or venous/arterial blood glucose · For: Cardiac Disease; PreDiabetes; Diabetes Mellitus
Sites: Seoul, South Korea
University of PennsylvaniaAcademic, hospital or other
NCT01474889 · 37 participants · Start Oct 2011 · Primary completion May 2016
Device: RT-CGM · For: Hypoglycemia Unawareness; Type 1 Diabetes; Healthy
Sites: Philadelphia, Pennsylvania · 3 sites in all
- Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 DiabetesPivotal-lookingCompleted
Jaeb Center for Health ResearchAcademic, hospital or other
NCT00406133 · 451 participants · Start Dec 2006 · Primary completion Jul 2008
Device: Continuous glucose monitor · For: Type 1 Diabetes
Sites: Beverly Hills, California; San Diego, California; Stanford, California · 11 sites in all
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Dexcom Seven", and for the whole product code for context.
This brand
9 reports: 8 malfunction, 1 injury, 0 death
Whole product code MDS
232,139 reports: 226,671 malfunction, 5,201 injury, 215 death
Newest reports for this brand
- DEXCOM SEVENInjury
MW5166752 · Received Feb 24, 2025 · Event dated Feb 19, 2025
Device type: Integrated Continuous Glucose Monitoring System, Factory Calibrated (QBJ)
Patient problem as coded: Insufficient Information
3004753838-2018-137136 · Received Nov 7, 2018 · Event dated Oct 15, 2018
Device type: Sensor, Glucose, Invasive (MDS)
Device problem as coded: Wireless Communication Problem
Patient problem as coded: No Consequences Or Impact To Patient
- DEXCOM SEVEN PLUS SYSTEMMalfunction
3004753838-2018-96183 · Received Aug 22, 2018 · Event dated Jan 1, 2013
Device type: Sensor, Glucose, Invasive (MDS)
Device problem as coded: Defective Alarm
Patient problem as coded: No Known Impact Or Consequence To Patient
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Dexcom Seven"[tiab]. The summary above synthesizes these.
- Retrofitting Real-Life Dexcom G5 Data.
Favero SD, Facchinetti A, Sparacino G, et al. · Diabetes Technol Ther · 2017Research Support, Non-U.S. Gov't
- Modeling the glucose sensor error.
Facchinetti A, Del Favero S, Sparacino G, et al. · IEEE Trans Biomed Eng · 2014
- Early hyperglycemia detected by continuous glucose monitoring in children at risk for type 1 diabetes.
Steck AK, Dong F, Taki I, et al. · Diabetes Care · 2014Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Ultrahigh-viscosity hydroxypropylmethylcellulose blunts postprandial glucose after a breakfast meal in women.
Dow S, Pritchett KL, Hawk S, et al. · J Am Coll Nutr · 2012Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- Methods of evaluating the utility of continuous glucose monitor alerts.
Kamath A, Mahalingam A, Brauker J · J Diabetes Sci Technol · 2010Clinical Trial, Research Support, Non-U.S. Gov't
- A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system.
Christiansen M, Bailey T, Watkins E, et al. · Diabetes Technol Ther · 2013Comparative Study, Evaluation Study
- Modeling the Error of the Medtronic Paradigm Veo Enlite Glucose Sensor.
Biagi L, Ramkissoon CM, Facchinetti A, et al. · Sensors (Basel) · 2017
- Modeling the effects of subcutaneous insulin administration and carbohydrate consumption on blood glucose.
Percival MW, Bevier WC, Wang Y, et al. · J Diabetes Sci Technol · 2010Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas.
Kovatchev BP, Renard E, Cobelli C, et al. · Diabetes Care · 2013Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center.
Luijf YM, Avogaro A, Benesch C, et al. · J Diabetes Sci Technol · 2012Comparative Study, Evaluation Study
- Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements.
Zisser HC, Bailey TS, Schwartz S, et al. · J Diabetes Sci Technol · 2009Clinical Trial, Comparative Study
- Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies.
Jacobs PG, El Youssef J, Castle J, et al. · IEEE Trans Biomed Eng · 2014Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MDS.
- Dexcom G4 Platinum Continuous Glucose Monitoring System and Dexcom 5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2018
- G5 Mobile Continuous Glucose Monitoring SystemDexcom, Inc. · PMA 2024
- FreeStyle Libre Pro Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc. · PMA 2020
- Freestyle Navigator Continuous Glucose Monitoring SystemAbbott Laboratories · PMA 2011
- Paradigm Real-Time Insulin PumpMedtronic Minimed · PMA 2015
- Medtronic Minimed Continuous Glucose Monitoring SystemMedtronic Minimed · PMA 2011
- Guardian Connect SystemMedtronic Minimed · PMA 2025
- Guardian RtMedtronic Minimed · PMA 2006
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.